Articles

Transitions Optical and the US National Council of Negro Women (NCNW) are collaborating to raise awareness about the importance of proper vision care and vision wear among the Africa-American community.

Investigators from The Scripps Research Institute, and Thomas Reh, PhD from the University of Washington, received the highest possible scores for their proposal to investigate the regenerative potential of retinal cells, resulting in a $4.66 million NIH Transformative Award.

AstraZeneca and UCL Institute of Ophthalmology are collaborating to develop regenerative medicines for diabetic retinopathy (DR).

opcon has launched the LENTIS Mplustoric intraocular lens (IOL.

Applied Genetics Technology Corporation (AGTC) has received a grant from the FDA (FDA Orphan Drugs Programme) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease.

A clinical trial is being conducted by the Cornea and Laser Eye Institute (CLEI) into the efficacy and safety of corneal collagen crosslinking (CXL) using riboflavin/dextran and hypotonic riboflavin in patients with progressive keratoconus and corneal ectasia.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

Doctors may be the first clinicians to detect the presence of a sexually transmitted disease (STD) when discovering ocular manifestations associated with STDs. However, since many of the ocular manifestations of STDs can be present with other conditions, further work is required.

A new multifocal IOL optic has been designed to overcome glare, halos, night vision difficulties and loss of contrast sensitivity present in current multifocal products.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

Dr Michael Trese explains how a web-based disease management imaging system could enhance screening for retinopathy of prematurity through acquisition and reading of weekly digital retinal images, hospital support and more opportunities for parental involvement.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

New findings from the ongoing African Descent and Glaucoma Evaluation Study (ADAGES) support previous results indicating that ancestry differences in visual function in healthy eyes are likely to be a sign of early disease.

Collaborative research has led to the development of an adaptive optics-optical coherence tomography (AO-OCT) system that allows ophthalmologists to see the eye's retina at the individual level.

Ophthalmic blogger, Irv Arons writes a tell all on what stem cells are all about, who's involved, who they are collaborating with, what type of stem cells they are using and what diseases they are aimed at.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

We report on a new excimer treatment for presbyopia.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

A glaucoma specialist outlines the seven deadly sins of glaucoma management that, if avoided, can greatly reduce the number of people who go blind from glaucoma. These points include making sure that diagnosis occurs promptly and that patient compliance is stressed.

Although near vision can never be assessed objectively, standardization between tests would be useful. However, there is a lack of standardization between tests so that comparison of results of different near vision tests is difficult, or not possible. Dr Oliver Findl explains.

A retrospective study analysed potential associations with giant cell formation in eyes with models of the flexible iris-fixated phakic IOL implanted.

We report on the first cataract and refractive femtosecond laser

A stem cell treatment to replace diseased parts of the retina is being pioneered by scientists funded by the Medical Research Council, the Macular Vision Research Foundation and Fight for Sight.

Results from research performed by St Jude Children's Research Hospital has demonstrated vision lost as a result of glaucoma, diabetic retinopathy and age-related macular degeneration (AMD) may be restored.

In a recent study published in the Archives of Ophthalmology researchers found that the recurrence of epithelial keratitis, stromal keratitis, conjunctivitis and blepharitis as a result of ocular herpes simplex virus (HSV) was decreased.

Findings from Retina Implant AG's first human clinical trial of subretinal electronic implants have revealed that useful vision can be restored and a significant cost-benefit to the patient's quality of life gained.

A polymer-based corneal prosthesis has been developed by the Fraunhofer Institute for Applied Polymer Research (IAP), Postdam-Golm, as part of the EU's Artificial Cornea project.

Avedro and Emery University have entered into an agreement to combine clinical trial data for corneal collagen cross-linking.